Literature DB >> 25246023

Primary intermediate-grade cardiac myxofibrosarcoma with osseous metaplasia: an extremely rare occurrence with a previously unreported feature.

Magdalena Sanchez-Uribe1, Juan Antonio Retamero2, J Gomez Leon3, Jorge Montoya Perez4, Enoe Quiñonez5.   

Abstract

Primary cardiac myxofibrosarcoma (MFS) is a very rare cardiac tumor with no more than 22 cases reported in the literature, including our case. We report an MFS arising in the left atrium in a 65-year-old woman who presented with pneumonia and cardiac failure. The 9.5-cm mass was diagnosed by echocardiogram. Histopathology examination showed an intermediate-grade MFS with osseous metaplasia, a feature that has not been reported before.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrium; Intermediate-grade; Myxofibrosarcoma; Osseous metaplasia

Mesh:

Year:  2014        PMID: 25246023     DOI: 10.1016/j.carpath.2014.07.006

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  4 in total

1.  Low grade myxofibrosarcoma in the right ventricle presenting as pulmonary thromboembolism.

Authors:  Jong Hui Suh; Do Yeon Kim; Jeong Seob Yoon; Eun Su Park; Chan Beom Park
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Myxofibrosarcoma of the scalp with difficult preoperative diagnosis: A case report and review of the literature.

Authors:  Xiao-Ting Ke; Xiong-Feng Yu; Ji-Yang Liu; Fang Huang; Mei-Gui Chen; Qing-Quan Lai
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 3.  Primary cardiac myxofibrosarcoma: case report, literature review and pooled analysis.

Authors:  Dandan Sun; Yupeng Wu; Yan Liu; Jun Yang
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

4.  Primary low grade myxofibrosarcoma of the liver with benign presentation but malignant outcome: a case report.

Authors:  Zigong Shao; Baoping Jiao; Juanhan Yu; Hao Liu
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.